Literature DB >> 24880750

Radio-neuroprotective effect of L-alpha-glycerylphosphorylcholine (GPC) in an experimental rat model.

Imola Plangár1, Emília Rita Szabó, Tünde Tőkés, Imola Mán, Kitti Brinyiczki, Gábor Fekete, István Németh, Miklós Ghyczy, Mihály Boros, Katalin Hideghéty.   

Abstract

Ionizing radiation plays a major role in the treatment of brain tumors, but side-effects may restrict the efficacy of therapy. In the present study, our goals were to establish whether the administration of L-alpha-glycerylphosphorylcholine (GPC) can moderate or prevent any of the irradiation-induced functional and morphological changes in a rodent model of hippocampus irradiation. Anesthetized adult (6-weeks-old) male Sprague-Dawley rats were subjected to 40 Gy irradiation of one hemisphere of the brain, without or with GPC treatment (50 mg/kg bw by gavage), the GPC treatment continuing for 4 months. The effects of this partial rat brain irradiation on the spatial orientation and learning ability of the rats were assessed with the repeated Morris water maze (MWM) test. Histopathologic (HP) evaluation based on hematoxylin-eosin and Luxol blue staining was performed 4 months after irradiation. The 40 Gy irradiation resulted in a moderate neurological deficit at the levels of both cognitive function and morphology 4 months after the irradiation. The MWM test proved to be a highly sensitive tool for the detection of neurofunctional impairment. The site navigation of the rats was impaired by the irradiation, but the GPC treatment markedly decreased the cognitive impairment. HP examination revealed lesser amounts of macrophage density, reactive gliosis, calcification and extent of demyelination in the GPC-treated group. GPC treatment led to significant protection against the cognitive decline and cellular damage, evoked by focal brain irradiation at 40 Gy dose level. Our study warrants further research on the protective or mitigating effects of GPC on radiation injuries.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24880750     DOI: 10.1007/s11060-014-1489-z

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  49 in total

1.  Molecular mechanisms mediating the effects of L-alpha-glycerylphosphorylcholine, a new cognition-enhancing drug, on behavioral and biochemical parameters in young and aged rats.

Authors:  G Schettini; C Ventra; T Florio; M Grimaldi; O Meucci; A Scorziello; A Postiglione; A Marino
Journal:  Pharmacol Biochem Behav       Date:  1992-09       Impact factor: 3.533

Review 2.  Pathogenesis of cognitive decline following therapeutic irradiation for head and neck tumors.

Authors:  Olubunmi K Abayomi
Journal:  Acta Oncol       Date:  2002       Impact factor: 4.089

3.  Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study.

Authors:  Nadia N Laack; Paul D Brown; Robert J Ivnik; Alfred F Furth; Karla V Ballman; Julie E Hammack; Robert M Arusell; Edward G Shaw; Jan C Buckner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-20       Impact factor: 7.038

Review 4.  Mechanisms and functional implications of adult neurogenesis.

Authors:  Chunmei Zhao; Wei Deng; Fred H Gage
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

5.  Anti-TNFA (TNF-alpha) treatment abrogates radiation-induced changes in vacular density and tissue oxygenation.

Authors:  Ramin Ansari; M Waleed Gaber; Bin Wang; Christopher B Pattillo; Curtis Miyamoto; Mohammad F Kiani
Journal:  Radiat Res       Date:  2007-01       Impact factor: 2.841

6.  Late effects of radiation on the central nervous system: role of vascular endothelial damage and glial stem cell survival.

Authors:  Jeffrey A Coderre; Gerard M Morris; Peggy L Micca; John W Hopewell; Ilja Verhagen; Bert J Kleiboer; Albert J van der Kogel
Journal:  Radiat Res       Date:  2006-09       Impact factor: 2.841

7.  Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data.

Authors:  L Parnetti; F Amenta; V Gallai
Journal:  Mech Ageing Dev       Date:  2001-11       Impact factor: 5.432

Review 8.  Pathways of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunction.

Authors:  F Amenta; S K Tayebati
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

9.  Loss of hippocampal neurogenesis, increased novelty-induced activity, decreased home cage activity, and impaired reversal learning one year after irradiation of the young mouse brain.

Authors:  Marie Kalm; Niklas Karlsson; Marie K L Nilsson; Klas Blomgren
Journal:  Exp Neurol       Date:  2013-01-16       Impact factor: 5.330

10.  Synthesis and antineoplastic properties of an ether glycerophosphonocholine, and analog of ET-18-OCH3-GPC.

Authors:  H Salari; S Howard; R Bittman
Journal:  Biochem Biophys Res Commun       Date:  1992-09-16       Impact factor: 3.575

View more
  2 in total

1.  l-Alpha Glycerylphosphorylcholine as a Potential Radioprotective Agent in Zebrafish Embryo Model.

Authors:  Emília Rita Szabó; Imola Plangár; Tünde Tőkés; Imola Mán; Róbert Polanek; Róbert Kovács; Gábor Fekete; Zoltán Szabó; Zsolt Csenki; Ferenc Baska; Katalin Hideghéty
Journal:  Zebrafish       Date:  2016-08-03       Impact factor: 1.985

2.  Targeting Mitochondrial Dysfunction with L-Alpha Glycerylphosphorylcholine.

Authors:  Gerda Strifler; Eszter Tuboly; Anikó Görbe; Mihály Boros; Daniella Pécz; Petra Hartmann
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.